Natalizumab for multiple sclerosis: A case in point for the impact of translational neuroimmunology

Afsaneh Shirani, Olaf Stüve

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab for multiple sclerosis: A case in point for the impact of translational neuroimmunology'. Together they form a unique fingerprint.

Medicine & Life Sciences